Real-world Data Market Poised to Reach $2.00 Billion by 2029

[Redding, California , 13-02-2024]- Meticulous Research®, a premier global market research company, has unveiled its latest report titled "Real-world Data (RWD) Market by Source (EMR, Claims, Pharmacy, Disease Registries), Application [Market Access, Drug Development & Approvals (Oncology, Neurology), Post-market Surveillance], End User (Pharma, Payers, Providers)- Forecast to 2029," shedding light on the promising future of the global real-world data (RWD) market.

Download Sample Report : https://www.meticulousresearch.com/download-sample-report/cp_id=5297

According to the findings of this comprehensive report, the global RWD market is poised to witness substantial growth, boasting a projected CAGR of 8.2% from 2022 to 2029, reaching a remarkable valuation of $2.00 billion by the end of the forecast period. This optimistic outlook is fueled by the rapid expansion of big data in healthcare, the paradigm shift from volume to value-based care, and a burgeoning focus on personalized healthcare. However, the market faces challenges stemming from the absence of standardized methodologies for RWD generation.

The incorporation of Artificial Intelligence (AI) into RWD studies emerges as a pivotal trend in the industry. AI-integrated RWD studies hold the promise of enhancing data anomaly detection, standardization, and quality control during the pre-processing phase. By leveraging AI techniques, RWD studies can effectively collect, organize, and analyze vast amounts of data sourced from disparate datasets. Furthermore, AI-powered wearable devices and sensors offer automated and continuous patient data collection, alleviating the burden on patients while facilitating real-time, power-efficient, mobile, and personalized patient data analysis.

Have Any Query ? Speak To Our Analyst : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5297

The global RWD market is segmented based on Source (EMR/EHR/Clinical Data, Claims & Billing Data, Pharmacy Data, Product/Disease Registries Data, Genomics Data, and Other Datasets), Application (Market Access & Reimbursement/Coverage Decisions, Drug Development & Approvals, Post-market Surveillance, Medical Device Development & Approvals, and Other Applications), End User (Pharmaceutical, Biotechnology, and Medical Device Companies, Healthcare Payers, Healthcare Providers, and Other End Users), and Geography. The report also provides a comprehensive analysis of industry competitors and their market share at both global and regional levels.

Quick Buy @ https://www.meticulousresearch.com/Checkout/62327099

Key Highlights:

In 2022, the EMR/EHR/clinical data segment is expected to dominate the RWD market, driven by the significant data volumes generated in hospitals and the increasing adoption of EHR/EMR systems.

The market access & reimbursement/coverage decisions segment is projected to hold the largest market share in 2022, fueled by the escalating demand for RWD to expedite drug discovery and development processes.

The pharmaceutical, biotechnology, and medical device companies segment are estimated to command the largest market share in 2022, attributed to the growing significance of RWD in drug development and approvals.

Top Trending Blog : https://meticulousblog.org/top-10-companies-in-real-world-data-rwd-market/

Geographically, the report offers a comprehensive analysis covering North America (U.S., Canada), Asia-Pacific (China, Japan, India, Australia, and RoAPAC), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Latin America, and the Middle East & Africa.

Leading Companies:

Key players shaping the global RWD market include Anthem, Inc. (U.S.), IQVIA Holdings Inc. (U.S.), ICON plc (Ireland), PPD Inc. (U.S.), Clinigen Group plc (U.K.), Cognizant Technology Solutions Corporation (U.S.), Oracle Corporation (U.S.), PAREXEL International Corporation (U.S.), PerkinElmer, Inc. (U.S.), SAS Institute Inc. (U.S.), UnitedHealth Group Incorporated (U.S.), and Flatiron Health, Inc. (U.S.).

Contact:
Meticuous Market Research Pvt Ltd
Office No-202, 203,204,205,206
2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad,
411057, India.
Phone: +9102066394988
CIN- U93000PN2013PTC149455

We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition. Through our mixed bag of research offerings - syndicated research, custom research, and analyst engagement - we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets.

This release was published on openPR.